Acyclovir Sodium Injection, Solution
NDC 55150-154
Product Information
Acyclovir Sodium is a ANDA-approved product labeled by Eugia Us Llc. This medication is used in certain people to treat outbreaks of herpes simplex infection of the skin (such as on the genitals), mucous membrane areas (such as the mouth, nose), or brain. It is supplied as a injection, solution for intravenous administration. This product entry covers the primary NDC 55150-154 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
- Intravenous - Administration within or into a vein or veins.
- Intravenous - Administration within or into a vein or veins.
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 55150-154?
What are the uses of this product?
What are Active Ingredients of this product?
- ACYCLOVIR SODIUM 500 mg/10mL - A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.
- ACYCLOVIR SODIUM 500 mg/10mL - A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ACYCLOVIR SODIUM (UNII: 927L42J563)
- ACYCLOVIR (UNII: X4HES1O11F) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1734932 - acyclovir sodium 500 MG in 10 ML Injection
- RxCUI: 1734932 - 10 ML acyclovir 50 MG/ML Injection
- RxCUI: 1734932 - 10 ML acycycloguanosine 50 MG/ML Injection
- RxCUI: 1734932 - acyclovir 50 MG/ML (equivalent to acyclovir sodium 54.9 MG/ML) per 10 ML Injection
- RxCUI: 1734932 - acyclovir 500 MG per 10 ML Injection
Which are the Pharmacologic Classes of this product?
- DNA Polymerase Inhibitors - [MoA] (Mechanism of Action)
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Nucleoside Analog - [EXT]
- DNA Polymerase Inhibitors - [MoA] (Mechanism of Action)
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Nucleoside Analog - [EXT]
* Please review the full disclaimer at the bottom of this page.
Patient Education
Acyclovir Injection
Acyclovir injection is used to treat first-time or repeat outbreaks of herpes simplex (a herpes virus infection of the skin and mucus membranes) and to treat herpes zoster (shingles; a rash that can occur in people who have had chickenpox in the past) in people with weak immune systems. It is also used to treat first-time genital herpes outbreaks (a herpes virus infection that causes sores to form around the genitals and rectum from time to time) in people with normal immune systems. Acyclovir injection is used to treat herpes simplex encephalitis (brain infection with swelling caused by the herpes virus) and herpes infections in newborn infants. Acyclovir injection is in a class of antiviral medications called synthetic nucleoside analogues. It works by stopping the spread of the herpes virus in the body. Acyclovir injection will not cure genital herpes and may not stop the spread of genital herpes to other people.
[Learn More]
* Please review the full disclaimer at the bottom of this page.